Injective (INJ) Staked ETF Debuts on Nasdaq as INJC

By Nodora News · 6 November 2026

Canary Capital's Canary Staked INJ ETF (INJC) began trading on Nasdaq on Nov. 5, giving brokerage investors Injective (INJ) exposure plus staking rewards.

Canary Capital's Canary Staked INJ ETF began trading on Nasdaq on Thursday, November 5, 2026, under the ticker INJC. The product is the first US exchange-traded fund built around Injective (INJ), the native token of the Injective Layer-1 network, and it is designed to hold INJ while staking most of that balance for network rewards. Injective (INJ) rose about 4% on OKX even as Bitcoin and Ether sold off with the wider market.

Key takeaways

• Canary Staked INJ ETF (ticker INJC) started trading on Nasdaq on November 5, 2026, after Nasdaq's listing notice for the same day.
• The fund seeks INJ price exposure plus staking rewards; under its prospectus it plans to stake at least 90% of its INJ in normal conditions.
• Fees include a 1.10% annual sponsor fee and staking-related fees expected to take about 30% of rewards, leaving roughly 70% for the trust.
• BitGo is named as custodian; Flow Traders U.S. LLC is the designated liquidity provider; the Injective Foundation has indicated it may seed up to $15 million of shares.
• INJ traded near $8.18 on OKX, up about 4.1% over 24 hours, while Bitcoin fell about 4.4%.

What Launched: Canary Staked INJ ETF (INJC) on Nasdaq

Canary Capital Group LLC said in a November 5 press release that the Canary Staked INJ ETF is now listed on Nasdaq. Nasdaq Trading Services had already told market makers the day before that listing would begin Thursday, November 5, with daily valuation dissemination starting the same session and Flow Traders U.S. LLC acting as Designated Liquidity Provider.

That closes the gap left after Nasdaq approved Canary's Form 8-A12B listing application on November 3. Nodora covered that Nasdaq listing approval for the Canary Staked INJ ETF when shares still could not be sold publicly. Thursday's debut means brokerage accounts can now trade the ticker.

The Block, The Defiant and CoinMarketCap Academy all reported the start of trading. Canary CEO Steven McClurg said the ETF "gives investors access to a blockchain purpose-built for finance through a familiar exchange-traded structure, while also enabling investors to benefit from potential staking rewards."

How the Injective (INJ) Staked ETF Is Built

INJC is not a 1940 Act mutual-fund-style ETF. It is an exchange-traded product that holds INJ rather than giving investors a direct wallet position. According to Canary's filings and launch materials:

• Objective: Track the price of INJ held in custody, minus fees and liabilities, and seek extra INJ through proof-of-stake validation on Injective.
• Staking target: Stake at least 90% of the trust's INJ under normal conditions, keeping some liquid for redemptions and expenses.
• Reward split: Staking-related fees are expected to take up to about 30% of rewards; the trust would keep roughly 70% before the separate 1.10% annual sponsor fee.
• Custody: BitGo Bank & Trust holds the tokens.
• Unbonding: Injective's 21-day undelegation period is a liquidity constraint the prospectus addresses with free INJ and, if needed, credit lines.
• Seed: The Injective Foundation has indicated intent to buy up to $15 million of shares as a seed investor, paid in INJ.

Injective Co-Founder Eric Chen said investors can now get INJ exposure "through the brokerage accounts they already use," without needing a crypto exchange account or self-custody keys. Staking rewards are not guaranteed and can fall; Canary's prospectus also flags slashing and related risks.

Why an Injective (INJ) ETF Matters Now

Spot bitcoin and ether ETFs already dominate US crypto fund flows. A staked INJ wrapper extends that model to a smaller Layer-1 aimed at on-chain trading, derivatives and tokenization. Canary's release says Injective has tokenized more than $1 billion in assets, processed more than 3.13 billion transactions as of October 22, 2026, and permanently burned more than 7.27 million INJ through monthly buybacks.

In August, Injective Institutional Services became an SEC-registered transfer agent. Two other US INJ products remain in the pipeline: a 21Shares Injective ETF and a REX-Osprey INJ Staking ETF. First-day net flows for INJC were not yet published in early reports; desks will compare them with recent altcoin debuts such as Bitwise's NEAR fund (~$35.5 million on day one).

For live major-coin prices, see Nodora's charts page. Broader US market-structure politics after the midterms remain unsettled; that backdrop is covered in our note on how Democratic control of Congress clouds the CLARITY Act.

Injective (INJ) Price Reaction on ETF Debut Day

INJ was one of the few large tokens in the green while Bitcoin and Ether sold off with AI-linked equities. OKX spot figures at the time of writing:

• INJ: about $8.18
• 24h change: roughly +4.1%
• 24h high / low: about $8.59 / $7.79
• Bitcoin (BTC): about $76,430 (−4.4%)
• Ethereum (ETH): about $2,266 (−5.9%)

CoinMarketCap Academy noted that INJ climbed after the approval news, dipped when Bitcoin slid at the US open, then recovered as INJC began trading. Futures open interest in INJ rose about 8% over 24 hours, per CoinGlass figures cited in that report. Past altcoin ETF debuts have not always lifted the underlying for long: Solana fell around Bitwise's October 2025 launch despite heavy first-day volume.

What to Watch After the INJC Nasdaq Debut

Several data points will decide whether Thursday's listing is a one-day headline or the start of lasting demand:

• First-day and first-week net flows into and out of INJC once issuers and trackers publish them.
• Share of assets staked each trading day, which the trust says it will disclose.
• INJ price vs. majors if the broader risk-off move continues.
• Competing INJ filings from 21Shares and REX-Osprey.
• Liquidity and spreads with Flow Traders as designated liquidity provider.

INJC is now a live Nasdaq ticker. It does not remove crypto market risk, and it is not a direct holding of INJ in a personal wallet. For US brokerage investors who wanted regulated exposure to Injective with a staking overlay, Thursday's open is the first session that product has been available to trade.

#Injective #INJ #ETF #Nasdaq #Canary Capital

This article is general information, not financial advice.